Conor McGregor said on Tuesday he was retiring from the sport, five months after losing to Khabib Nurmagomedov in a controversial title fight
Prosecutors unveiled charges against Valvani alleging he fraudulently made $25 million by getting advance information about US Food and Drug Administration approvals of generic drug applications
According to market experts, GST Bill, movement of the rupee and uncertain global cues amid expected rate cut by the US Fed will dictate the movement of the markets.
Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.
On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.
Maggi re-entered the market on November 9.
Nestle on Monday started a market rollout of Maggi noodles.
Companies that are developing biosimilars (for regulated markets) or have portfolio of new chemical entities (NCEs) under development.
The S&P BSE Sensex ended down 371 points at 24,966 and the Nifty50 closed 101 points lower at 7,615.
The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.
In 2008, Daiichi Sankyo had bought the entire 34.82 per cent stake in Ranbaxy from its promoters, Malvinder Mohan Singh and family, for $4.2 billion. Currently, Singh is executive chairman of Fortis Healthcare.
Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees
Sun Pharma would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy facilities but it has not put any time-frame for this, company ChairmanIsrael Makov said.
The trouble for Nestle's Maggi started in Uttar Pradesh last month and has now spread nationwide. The Food and Drug Administration has directed all states on Wednesday to get sample of India's most popular instant noodles tested for high content of lead and mono-sodium glutamate, a taste enhancer.
Investors turn their attention to export-driven sectors.
Indian equity markets registered their highest single-day percentage gains since early October.
On October 16, Nestl received the go-ahead to resume manufacturing Maggi.
Market breadth is positive with 942 advances and 196 declines.
IT shares lost ground tracking a sell-off in tech stocks on Nasdaq on Friday
A single-member commission under retired judge Anita Jha was constituted on Firday to probe the botched sterilisation surgeries at Bilaspur's government-run medical camps, which have so far claimed lives of 13 young women and left nearly 138 ill, and asked to submit its report within three months.
The S&P BSE Sensex closed at 26,190, up by 43 points and Nifty50 settled above 7,950 to end at 7,963, up by 17 points
Benchmark indices finished higher on hopes of economic reforms
The top gainers on the Sensex were Cipla, Bharti Airtel, Maruti Suzuki, Hero Moto & Sesa Sterlite.
The challenge of merging Ranbaxy into the company has not been factored in.
Sensex, Nifty put up a good show in closing trade.
The higher rate cut by RBI is positive for rate-sensitive sectors in the medium to long term.
Stockmarket Gurus Raamdeo Agrawal, Manish Gunwani, S Naren and Nilesh Shah discuss their favourite themes for the New Year.
The S&P BSE Sensex gained 115 points to end at 24,338 and the Nifty50 climbed 42 points to close at 7,404.
'There are different kinds of risk.' 'It is a very powerful value. Your ability to de-risk the risk is also as important for risk taking.'
Financials ended mixed despite the status-quo on key rates by the RBI. SBI, ICICI Bank and Axis Bank ended up 0.4-2.5% each.
Gains were led by index heavyweights with Reliance Industries contributing the most.
Indices reversed all its losses during late trades.
Move follows a spate of international regulatory enforcements on Indian drug firms.
Market breadth continued to remain strong, with 1899 gainers and 674 losers on the BSEs.
Stellar rally in ITC shares along with strength in the Asian equities capped the downside.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
'We have created an enemy we can't even see and that enemy is entertaining us while tightening the noose around our necks.' 'As the radiation increases, it will affect everything -- from your little bumble bee to plants to every living cell.' 'By the time the effects are understood, it might be too late.'
'This is a stirring, touching film but it stays impressively away from overt manipulation.' 'It is a film about smarts,' says Raja Sen after watching Dallas Buyers' Club.
The 30-share Sensex ended up 292 points at 29,571 and the 50-share Nifty closed up 75 points at 8,910.
BSE Midcap and Smallcap indices ended in line with their larger counterparts and closed marginally up 0.2% and 0.4%, each
